Editor's Picks (Total records: loading...)
Drug Manufacturers
Gilead Sciences Inc (GILD) Q4 2025 Earnings Call Highlights: Strong HIV Sales Drive Growth Amidst Competitive Challenges
Gilead Sciences Inc (GILD) reports robust HIV sales growth and outlines strategic initiatives for 2026, despite facing competitive pressures in cell therapy. 18 minutes ago
Medical Devices & Instruments
Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments
Edwards Lifesciences Corp (EW) reports robust Q4 2025 results with an 11.6% sales increase, while navigating challenges in EPS and strategic spending. 20 minutes ago
Chemicals
Ecolab Inc (ECL) Q4 2025 Earnings Call Highlights: Record-Breaking Growth and Strategic Acquisitions Propel Future Prospects
Ecolab Inc (ECL) reports robust Q4 2025 performance with significant EPS growth and strategic initiatives setting the stage for continued success in 2026. 4 hours ago
Asset Management
Principal Financial Group Inc (PFG) Q4 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Divestitures Drive Performance
Principal Financial Group Inc (PFG) reports robust earnings growth and strategic focus on high-return businesses, despite challenges in international segments. 8 hours ago
Capital Markets
S&P Global Inc (SPGI) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic AI Initiatives
S&P Global Inc (SPGI) reports robust financial performance with significant EPS growth and continued shareholder returns, while navigating market challenges and advancing AI integration. 8 hours ago
Travel & Leisure
Marriott International Inc (MAR) Q4 2025 Earnings Call Highlights: Strong Fee Revenue Growth and Record Pipeline
Marriott International Inc (MAR) reports robust financial performance with significant growth in fee revenues and a record pipeline of rooms, despite challenges in select segments. 8 hours ago
Medical Diagnostics & Research
Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Collaborations Propel Future Outlook
Quest Diagnostics Inc (DGX) reports robust financial performance with significant revenue growth and strategic initiatives, setting a positive tone for 2026 despite challenges. 8 hours ago



















